Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 4, 2007. The report discloses a notification of major interests in the company's ordinary shares received from Legal & General Group plc on December 3, 2007, pursuant to Disclosure and Transparency Rule 5.8.12.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding share ownership thresholds rather than a financial performance report.
Material Changes
The primary material change disclosed is the acquisition of voting rights by Legal & General Group plc and its subsidiaries, causing them to cross the 5% ownership threshold.
- Previous Position: Below 5% (255,111,994 shares representing 4.62% direct voting rights).
- Resulting Position: 5.00% total voting rights (276,137,003 shares).
- Transaction Date: November 30, 2007.
Outlook, Risks, and Management Commentary
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details the chain of controlled undertakings holding the shares, including Legal & General Investment Management Limited and Legal & General Assurance (Pensions Management) Limited.
Investor Verification Checklist
- Verify the total number of voting rights held by Legal & General Group plc (276,137,003).
- Confirm the total voting rights base used for the percentage calculation (5,521,203,804).
- Review the breakdown of direct versus indirect holdings within the Legal & Group structure.
- Check for subsequent filings to monitor if the stake increases beyond the 5% threshold.